Medical News / Malignancy & Serious Infections with JAK Inhibitors for RA Treatment
While the US Food and Drug Administration (FDA) has 2 Janus kinase (JAK) inhibitors currently approved for the treatment of rheumatoid arthritis (RA), the treatments’ safety profiles have been of interest since their approval due to their suspected risk of developing malignancies or serious infections.
read more
MORE MEDICAL NEWS
In data presented as a late-breaking abstract during Digestive Disease Week (DDW) 2023 in Chicago, a ... read more
Direct endoscopic necrosectomy at index session, as opposed to the step-up approach, for patients with infected ... read more
Gut dysbiosis is often linked to persistent multi-system symptoms after SARS-CoV-2 infections or post-acute COVID-19 syndrome.
In ... read more
[1].jpg)
The explosion of artificial intelligence has permeated through basically all walks of life, including medicine.
In an ... read more